Short-course radiation plus temozolomide in elderly patients with glioblastoma

New England Journal of Medicine

Volumn 376, Issue 11, 2017, Pages 1027-1037

  Perry, James R ^a   Laperriere, Normand ^b   O'Callaghan, Christopher J ^c   Brandes, Alba A ^h   Menten, Johan ^j   Phillips, Claire ^k   Fay, Michael ^l,m   Nishikawa, Ryo ^o   Cairncross, J Gregory ^d   Roa, Wilson ^e   Osoba, David ^f   Rossiter, John P ^c   Sahgal, Arjun ^a   Hirte, Hal ^g   Laigle Donadey, Florence ^p   Franceschi, Enrico ^h   Chinot, Olivier ^q   Golfinopoulos, Vassilis ^r   Fariselli, Laura ⁱ   Wick, Antje ^s   Feuvret, Loic ^p   Back, Michael ⁿ   Tills, Michael ^t   Winch, Chad ^c   Baumert, Brigitta G ^u   Wick, Wolfgang ^s   Ding, Keyue ^c   Mason, Warren P ^b   more..

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f Quality of Life Consulting   (Canada)

^g JURAVINSKI CANCER CENTRE   (Canada)

^h Azienda USL di Bologna   (Italy)

ⁱ DEPARTMENT OF NEUROSURGERY   (Italy)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k PETER MACCALLUM CANCER CENTRE   (Australia)

^l UNIVERSITY OF NEWCASTLE   (Australia)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ ROYAL NORTH SHORE HOSPITAL   (Australia)

^o SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^p PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^q AIX MARSEILLE UNIVERSITY   (France)

^r EORTC DATA CENTER   (Belgium)

^s UNIVERSITY OF HEIDELBERG   (Germany)

^t TAURANGA HOSPITAL   (New Zealand)

^u MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; DACARBAZINE;

ADJUVANT THERAPY; AGED; ANEMIA; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEATH; DISEASE COURSE; DRUG FATALITY; ELDERLY CARE; FEMALE; GLIOBLASTOMA; HAZARD RATIO; HUMAN; HUMAN TISSUE; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT DURATION; ANALOGS AND DERIVATIVES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMORADIOTHERAPY; CLINICAL TRIAL; MORTALITY; MULTICENTER STUDY; PROCEDURES; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; QUALITY OF LIFE; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 85015918057     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1611977     Document Type: Article

References (22)

1. Paszat L, Laperriere N, Groome P., Schulze K, Mackillop W, Holowaty E. A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001; 51:100-7.
2. Laperriere N, Weller M, Stupp R., et al. Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 2013; 39:350-7.
3. Ostrom QT, Gittleman H, Fulop J., et al. Central Brain Tumor Registry of the United States (CBTRUS) statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 2015; 17: Suppl 4: 1-62.
4. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96.
5. Brandes AA, Franceschi E, Tosoni A., et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 2009; 115:3512-8.
6. Keime-Guibert F., Chinot O, Taillandier L., et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007; 356: 1527-35.
7. Malmström A., Grønberg BH, Marosi C., et al. Temozolomide versus standard 6-week radiotherapy versus hypofraction-ated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 2012; 13:916-26.
8. Wick W, Platten M, Meisner C., et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 2012; 13: 707-15.
9. Minniti G, Salvati M, Arcella A., et al. Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol 2011; 102:311-6.
10. Reifenberger G, Hentschel B, Felsberg J., et al. Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer 2012; 131: 1342-50.
11. Vlassenbroeck I, Califice S, Diserens A.C., et al. Validation of real-time methylation-specific PCR to determine O6-meth-ylguanine-DNA methyltransferase gene promoter methylation in glioma. J Mol Diagn 2008; 10:332-7.
12. Ellenberg SS, Eisenberger MA An efficient design for phase III studies of combination chemotherapies. Cancer Treat Rep 1985; 69:1147-54.
13. Mason M, Laperriere N, Wick W., et al. Glioblastoma in the elderly: making sense of the evidence. Neuro Oncol Pract 2016; 2:77-86.
14. Iwamoto FM, Reiner AS, Panageas K.S., Elkin EB, Abrey LE. Patterns of care in elderly glioblastoma patients. Ann Neurol 2008; 64:628-34.
15. Barnholtz-Sloan J.S., Williams VL, Maldonado J.L., et al. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 2008; 108:642-8.
16. Lowry JK, Snyder JJ, Lowry PW Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 1998; 55:922-8.
17. Bauman GS, Gaspar LE, Fisher B.J., Halperin EC, Macdonald DR, Cairncross JG. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994; 29:835-9.
18. Roa W, Brasher PM, Bauman G, et al Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004; 22: 1583-8.
19. Glantz M, Chamberlain M, Liu Q., Litofsky NS, Recht LD. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 2003; 97:2262-6.
20. Chinot OL, Barrie M, Frauger E., et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 2004; 100:2208-14.
21. Chamberlain MC, Chalmers L. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol 2007; 82:207-9.
22. Laigle-Donadey F., Figarella-Branger D, Chinot O., et al. Up-front temozolomide in elderly patients with glioblastoma. J Neurooncol 2010; 99:89-94.